Walnut extract may offer cell protection against oxidative stress and cell death caused by amyloid beta-protein, the major components of amyloid deposits found in the brain of Alzheimer’s disease sufferers.
According to a new in vitro study published in Neurochemical Research,walnut extract may offer cell protection against oxidative stress and cell death caused by amyloid beta-protein, the major components of amyloid deposits found in the brain of Alzheimer’s disease sufferers.
Amyloid beta-protein is said to be a major component of senile plaque, increasing free radical production in neuronal cells, which can lead to oxidative stress and cell death. Researchers say that walnuts are rich in antioxidants and anti-inflammatory properties that may help protect against such degeneration.
“Walnuts are a nutrient-dense whole food that not only provides antioxidants but also alpha-linolenic acid (ALA), the plant-based omega-3 fatty acid. These components of walnuts offer anti-inflammatory properties and protect brain cells from oxidative damage,” said Abha Chauhan, PhD, one of the researchers and head of the developmental neuroscience lab at the NYS Institute for Basic Research in Developmental Disabilities.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.